- Home
- MEDP vs SF Comparison
MEDP vs SF Comparison
Compare MEDP & SF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MEDP
- SF
- Stock Information
- Founded
- MEDP 1992
- SF 1890
- Country
- MEDP United States
- SF United States
- Employees
- MEDP N/A
- SF N/A
- Industry
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- SF Investment Bankers/Brokers/Service
- Sector
- MEDP Health Care
- SF Finance
- Exchange
- MEDP Nasdaq
- SF Nasdaq
- Market Cap
- MEDP 10.5B
- SF 12.0B
- IPO Year
- MEDP 2016
- SF N/A
- Fundamental
- Price
- MEDP $340.22
- SF $103.90
- Analyst Decision
- MEDP Buy
- SF Hold
- Analyst Count
- MEDP 10
- SF 8
- Target Price
- MEDP $389.89
- SF $117.71
- AVG Volume (30 Days)
- MEDP 310.8K
- SF 702.5K
- Earning Date
- MEDP 02-10-2025
- SF 01-29-2025
- Dividend Yield
- MEDP N/A
- SF 1.78%
- EPS Growth
- MEDP 42.23
- SF 46.03
- EPS
- MEDP 12.63
- SF 6.25
- Revenue
- MEDP $2,109,054,000.00
- SF $4,970,320,000.00
- Revenue This Year
- MEDP $7.54
- SF $15.10
- Revenue Next Year
- MEDP $11.55
- SF $9.19
- P/E Ratio
- MEDP $27.15
- SF $16.49
- Revenue Growth
- MEDP 11.84
- SF 14.95
- 52 Week Low
- MEDP $302.01
- SF $72.78
- 52 Week High
- MEDP $459.77
- SF $120.64
- Technical
- Relative Strength Index (RSI)
- MEDP 47.17
- SF 34.24
- Support Level
- MEDP $336.78
- SF $106.48
- Resistance Level
- MEDP $347.58
- SF $111.62
- Average True Range (ATR)
- MEDP 12.05
- SF 2.66
- MACD
- MEDP -0.79
- SF -0.88
- Stochastic Oscillator
- MEDP 34.48
- SF 7.56
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
About SF Stifel Financial Corporation
Stifel Financial is a middle-market-focused investment bank that produces more than 90% of its revenue in the United States. Approximately 60% of the company's net revenue is derived from its global wealth management division, which supports over 2,000 financial advisors, with the remainder coming from its institutional securities business. Stifel has a history of being an active acquirer of other financial-services firms.